Abstract
[...]Model 2 [Figure 1C–D] and Model 3 [Figure 1E–F] achieved 100% specificity in predicting efficacy and were able to independently predict CAR-T-cell therapy efficacy, with a P-value of 0.001 [Supplementary Table 5, http://links.lww.com/CM9/C191]. [...]while the choice of costimulatory domain might affect CAR-T-cell therapy efficacy, our study did not address this potential influence. [...]our research successfully developed and validated an index system for assessing the efficacy of CD19 CAR-T-cell therapy in patients with r/r DLBCL. Funding This work was supported by grants from the National Key R&D Program of China (No. 2021YFA1100800), National Natural Science Foundation of China (Nos. 81830004 and 82070168), Translational Research Grant of NCRCH (No. 2020ZKZC04), Shanghai Municipal Health Commission (No. 2020CXJQ02), and Cultivation project of National Natural Science Foundation of Shanghai Tongji Hospital (No.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Department of Hematology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China
2 Department of Hematology, Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai 200065, China; Department of Hematology, Ningbo No.2 Hospital, Ningbo, Zhejiang 315010, China
3 Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, China
4 Department of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200001, China